2022年8期
刊物介紹
期刊簡介 《老年心臟病學(xué)雜志（英文版）》(Journal of Geriatric Cardiology, JGC)是由中國人民解放軍總醫(yī)院主管、解放軍總醫(yī)院老年心血管病研究所主辦、科學(xué)出版社第二主辦的國際性醫(yī)學(xué)學(xué)術(shù)期刊。該雜志創(chuàng)刊于2004年，國際標(biāo)準(zhǔn)刊號ISSN1671-5411，國內(nèi)統(tǒng)一刊號CN11-5329/R。《老年心臟病學(xué)雜志（英文版）》致力于國際老年心臟病學(xué)交流，特別是將國內(nèi)老年心臟病學(xué)及相關(guān)領(lǐng)域的學(xué)術(shù)進(jìn)展介紹給國外同行。主要欄目有臨床研究、基礎(chǔ)研究、綜述、病例報告、專題論文集、讀者來信等。目前該刊已經(jīng)被SCIE、PubMed Central (PMC)、Scopus、EMBase、Chemical Abstract（CA）、DOAJ、Chinese Science Citation Database (CSCD)、WanFang Data、CAS-OAJ、Open J-Gate 及Google Scholar等國內(nèi)、國際重要文獻(xiàn)檢索系統(tǒng)收錄, 是中國大陸心血管領(lǐng)域第一本被SCI收錄的期刊。 特色與優(yōu)勢 快速評審：所有來稿均可在一個月內(nèi)得到審稿意見，接受稿件可在三個月內(nèi)發(fā)表；評審專家陣容強(qiáng)大：我們有來自世界各地的360名心血管領(lǐng)域?qū)＜覟槲覀儗徃?能保證每篇稿件的審稿質(zhì)量，即使您的文章經(jīng)評審后不能在本雜志上發(fā)表，詳盡的評審意見也會對您的研究起到非常好的促進(jìn)作用；文章可見度高：本刊目前被許多國際著名醫(yī)學(xué)數(shù)據(jù)庫收錄，比如SCIE、PubMed、Scopus、 EMBase等，保證了每篇發(fā)表文章的可見度。
Journal of Geriatric Cardiology
LETTER TO THE EDITOR
- Extracorporeal membrane oxygenation successfully treated massive right ventricular myocardial infaction with aneurysm
- Takotsubo syndrome presenting with left bundle branch block in an octogenarian. Is hyponatremia a pathogeni c “common ground”?
- The feasibility of leadless pacemaker implantation in nonagenarians: case report and literature review
RESEARCH ARTICLE
- Long-term outcome of percutaneous or surgical revascularization with and without prior stroke in patients with threevessel disease
- Relationship between arterial stiffness and cognitive function in outpatients with dementia and mild cognitive impairment compared with community residents without dementia
- Serum triglycerides concentration in relation to total and cardiovascular mortality in an elderly Chinese population
- The predictive value of triglyceride-glucose index for in-hospital and one-year mortality in elderly non-diabetic patients with ST-segment elevation myocardial infarction
- Inflammation-based different association between anatomical severity of coronary artery disease and lung cancer
- Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation